Workflow
PSMA PET CT imaging for prostate cancer
icon
Search documents
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Seeking Alpha· 2026-03-05 05:42
Group 1 - The webinar focuses on innovations in PSMA PET CT imaging for prostate cancer, featuring key opinion leaders and subject matter experts [1] - The panel discussion is moderated by Dr. David Cade, Chief Medical Officer at Telix, and includes notable speakers from prestigious institutions [2] - The discussion aims to provide insights from a physician's perspective on advancements in imaging technology for prostate cancer [1][2] Group 2 - The speakers include Rodney Hicks, a Professor of Medicine and Chief Medical Officer at the Melbourne Theranostic Innovation Center, and Dr. Paul Yonover, Chief Data Officer at UroPartners [2] - Darren Patti serves as the Chief Operating Officer of Telix, contributing to the operational insights during the discussion [2]